Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.6B | 16.0B | 13.6B | 14.2B |
Cost of revenue | 7.9B | 10.8B | 7.7B | 7.9B |
Gross profit | 5.7B | 5.1B | 6.0B | 6.3B |
Operating expense | ||||
Research & development | — | 234.1M | 262.2M | 170.4M |
Selling general and admin | 2.6B | 1.6B | 1.8B | 2.4B |
Other operating expenses | — | 120.8M | 55.3M | 87.9M |
Operating income | 5.7B | 1.7B | 2.3B | 1.3B |
Non operating interest income | ||||
Income | — | 85.2M | 107.5M | 102.2M |
Expense | — | 45.3M | 56.0M | 36.2M |
Other income expense | — | — | — | — |
Pretax income | 3.7B | 1.2B | 2.6B | 1.1B |
Tax provision | 660.3M | 590.7M | 653.1M | 151.4M |
Net income | 3.1B | 645.3M | 1.9B | 949.0M |
Basic EPS | 557.8 | — | 347 | 171 |
Diluted EPS | 557.8 | — | 347 | 171 |
Basic average shares | — | — | 6.0M | 6.4M |
Diluted average shares | — | — | 6.0M | 6.4M |
EBITDA | 5.7B | 3.9B | 2.8B | 2.5B |
Net income from continuing op. | — | 645.3M | 1.9B | 949.0M |
Minority interests | 12.0M | 6.3M | 155.1M | 141.4M |
Preferred stock dividends | — | — | — | — |